INTRAVENOUS CLARITHROMYCIN: A VALUABLE IMMUNOMODULATOR FOR SEVERE INFECTIONS
There are many studies suggesting that intake of a macrolide in the treatment regimen is linked with improved outcomes for patients with community-acquired pneumonia. However this was never proved through one randomized clinical study (RCT). We reviewed all pre-clinical and clinical development from...
Main Authors: | Leventogiannis Konstantinos, Giamarellos-Bourboulis J. Evangelos |
---|---|
Format: | Article |
Language: | English |
Published: |
Association of medical doctors Sanamed Novi Pazar
2014-04-01
|
Series: | Sanamed |
Subjects: | |
Online Access: | http://www.sanamed.rs/sanamed_pdf/sanamed_9_1/Konstantinos_Leventogian.pdf |
Similar Items
-
Intravenous clarithromycin: A valuable immunomodulator for severe infections
by: Leventogiannis Konstantinos, et al.
Published: (2014-01-01) -
Effect of intravenous clarithromycin in patients with sepsis, respiratory and multiple organ dysfunction syndrome: a randomized clinical trial
by: Eleni Karakike, et al.
Published: (2022-06-01) -
Time-dependent effect of clarithromycin on pro-inflammatory cytokines in CRS
by: Ana Catarina Pratas, et al.
Published: (2022-07-01) -
The Efficacy of Clarithromycin in Patients with Severe Nasal Polyposis
by: Payman Dabirmoghaddam, et al.
Published: (2013-06-01) -
Kaempferia parviflora Extracellular Vesicle Loaded with Clarithromycin for the Treatment of Helicobacter pylori Infection
by: Nemidkanam V, et al.
Published: (2024-02-01)